my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
BiPar Sciences is a privately held biopharmaceutical company pioneering novel tumor-selective therapies designed to address urgent unmet needs of cancer patients, with headquarters in Brisbane, California. In addition to BSI-201, the company also has two additional compounds in pre-clinical developm more
Sanofi-aventis and its wholly owned subsidiary, BiPar Sciences, announced the initiation of the pivotal Phase III trial for BSI-201 in combination with chemotherapy in patients with metastatic triple-negative breast cancer (mTNBC), defined by tumors lacking expression of estrogen, progesterone recep more
Sanofi-aventis announced that it has signed a binding agreement for the acquisition of BiPar Sciences, Inc., a privately held US biopharmaceutical company, developing novel tumorselective approaches for the treatment of different types of cancers. BiPar is a company in the emerging field of DNA (De more
What will this decade hold for leading anti-cancer drugs and that therapeutic market? Our new report shows you anti-cancer drug revenue forecasts for 2011 to 2021. We provide research, data and opinions to benefit your work now. What revenues will cancer treatment markets generate from 2011 to 2021 more
Introduction Small molecule targeted therapies represent a highly lucrative class of anticancer therapies with 12 drugs currently approved for various tumor types. This promise of high commercial rewards has driven considerable pipeline activity for small molecule targeted therapies within cancer. more
Contact Us Business Development Future Products Lead Product Target Pre-clinical Summary Clinical Studies Technology Team Management Team Board of Directors Scientific Advisors Home News & Events Board of Directors Pratik Shah, Ph.D. Chairman and Director Pratik is a partner at Thomas, McNerney & Pa more
about us executive management board of directors scientific advisory board allosteric modulation pipeline key indications business development investor center press releases careers contact board of directors home > about us > board of directors André J. Mueller , (Chairman), former CFO of Acteli more
Free Newsletter! BioValley.com BioValley Region Home About BioValley BioValley Guide News Events Links Job Market Contact Us Press releases and articles Focus of the month International News Newsletter » Top Viewed » Most Commented Related Topics » Research » Manufacturing » Biotechnolog more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
